Perret G, Hugues J N, Louchahi M, Varoquaux O, Modigliani E
Pharmacology. 1986;32(2):101-8. doi: 10.1159/000138157.
Cimetidine (400 mg b.d.), ranitidine (150 mg b.d.) and placebo were administered for 1 week to 6 healthy male volunteers in a randomized double-blind cross-over fashion. Hormonal concentrations before and after a TRH test were assessed before and after each treatment. A spontaneous decrease in the hormonal response to TRH was observed after placebo treatment. Both cimetidine and ranitidine induced a significant increase in basal prolactin (PRL) values. Neither TSH nor T3 were modified by cimetidine or by ranitidine. The basal concentration of reverse T3 was increased during cimetidine treatment. There was a significant rise in post-TRH T4 after cimetidine and ranitidine administration. These results suggest a role for histamine H2 receptors in the secretion of PRL and T4. Moreover, cimetidine affects the hepatic metabolism of thyroid hormones.
以随机双盲交叉方式,给6名健康男性志愿者服用西咪替丁(每日两次,每次400毫克)、雷尼替丁(每日两次,每次150毫克)和安慰剂,为期1周。在每次治疗前后,评估促甲状腺激素释放激素(TRH)试验前后的激素浓度。安慰剂治疗后,观察到对TRH的激素反应自发下降。西咪替丁和雷尼替丁均使基础催乳素(PRL)值显著升高。西咪替丁或雷尼替丁对促甲状腺激素(TSH)和三碘甲状腺原氨酸(T3)均无影响。西咪替丁治疗期间,反三碘甲状腺原氨酸(reverse T3)的基础浓度升高。服用西咪替丁和雷尼替丁后,TRH刺激后的甲状腺素(T4)显著升高。这些结果表明组胺H2受体在PRL和T4分泌中起作用。此外,西咪替丁影响甲状腺激素的肝脏代谢。